|4Jan 28, 6:56 PM ET

Payne Fletcher 4

4 · CATALYST BIOSCIENCES, INC. · Filed Jan 28, 2019

Insider Transaction Report

Form 4
Period: 2019-01-24
Payne Fletcher
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-01-24+38,00038,000 total
    Exercise: $7.97Exp: 2029-01-24Common Stock (38,000 underlying)
Footnotes (1)
  • [F1]Award vests over a four (4) year period on each monthly anniversary commencing January 24, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION